ASCENT THERAPEUTICS
Ascent Therapeutics is pioneering a new class of drugs called pepducins. Pepducins are a breakthrough approach to targeting G-protein coupled receptors (GPCRs) on the inside surface of the cell membrane, dramatically expanding the GPCR frontier. GPCRs are critically involved in a wide variety of serious illnesses, including inflammation, cancer, metabolic CNS disorders and cardiovascular disease. Pepducin technology represents an exciting new area of research directed towards a well-validated class of drug targets.
ASCENT THERAPEUTICS
Industry:
Biotechnology Health Care Medical
Founded:
2006-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.ascentrx.com
Total Employee:
1+
Status:
Active
Contact:
617-715-1999
Email Addresses:
[email protected]
Total Funding:
19 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible GoDaddy DNS Google Google Cloud OpenResty Google Adsense Google Cloud Global Multi-Region AdBlock Acceptable Ads Google Adsense For Domains
Investors List
HealthCare Ventures
HealthCare Ventures investment in Series A - Ascent Therapeutics
TVM Capital
TVM Capital investment in Series A - Ascent Therapeutics
Novartis Venture Fund
Novartis Venture Fund investment in Series A - Ascent Therapeutics
Official Site Inspections
http://www.ascentrx.com
- Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
- IP address: 3.33.130.190
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
